Table 3

Proportions of patients with lesions seen on MRI of the spine

ASAS classification 2/3 readersNo SpAPossible axSpAClinical arm onlyMRI +mNY−mNY+
No. of patients6989535122
Inflammatory lesions ≥12529192712
%36.332.635.852.954.5
Inflammatory lesions ≥21519111811
%21.721.320.835.350.0
Inflammatory lesions ≥311106129
%15.911.211.323.540.9
Inflammatory lesions477499
%10.17.97.517.640.9
Inflammatory lesions524276
%2.94.53.813.727.3
Fatty lesions ≥11824132411
%26.127.024.547.150.0
Fatty lesions ≥211168179
%15.918.015.133.340.9
Fatty lesions ≥3993136
%13.010.15.725.527.3
Fatty lesions4672114
%8.77.93.821.618.2
Fatty lesions5361114
%4.36.71.921.618.2
Erosions ≥1232416155
%33.327.030.229.422.7
Erosions ≥21010584
%14.511.29.415.718.2
Erosions354443
%7.24.57.57.813.6
Erosions424121
%2.94.51.93.94.5
Syndesmophytes ≥117218192
%24.623.615.137.39.1
Syndesmophytes2611560
%8.712.49.411.8
Syndesmophytes357330
%7.27.95.75.9
Syndesmophytes423210
%2.93.43.82.0
  • False positives ≤10% in italic; false positives ≤5% in italic and bold.

  • ASAS, Assessment of Spondyloarthritis international Society; axSpA, axial spondyloarthritis; mNY, modified New York criteria; SpA, spondyloarthritis.